Search research articles
Contact Us
Filters
Showing results (151-160 of 168) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer
Cristiano Ferrario, John Mackey, Karen A Gelmon, et al.
The Journal of Clinical Investigation
|
October 17, 2017
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
Yao Zhan, Jun Guo, William Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Molecular Cancer Therapeutics
|
February 1, 2023
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, et al.
Cell Reports
|
March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma
Diana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
The New England Journal of Medicine
|
February 20, 2019
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Robert J Motzer, Konstantin Penkov, John Haanen, et al.
Cancer Research
|
January 20, 2019
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <i>In Situ</i>
Qianyu Guo, Vivian Z Li, Jessica N Nichol, et al.
The Lancet. Oncology
|
March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S Weber, Sandra P D'Angelo, David Minor, et al.
The New England Journal of Medicine
|
August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation
Adrian Sacher, Patricia LoRusso, Manish R Patel, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 168) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer
Cristiano Ferrario, John Mackey, Karen A Gelmon, et al.
The Journal of Clinical Investigation
|
October 17, 2017
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
Yao Zhan, Jun Guo, William Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Molecular Cancer Therapeutics
|
February 1, 2023
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
Sathyen A Prabhu, Omar Moussa, Christophe Gonçalves, et al.
Cell Reports
|
March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma
Diana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
The New England Journal of Medicine
|
February 20, 2019
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Robert J Motzer, Konstantin Penkov, John Haanen, et al.
Cancer Research
|
January 20, 2019
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <i>In Situ</i>
Qianyu Guo, Vivian Z Li, Jessica N Nichol, et al.
The Lancet. Oncology
|
March 22, 2015
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S Weber, Sandra P D'Angelo, David Minor, et al.
The New England Journal of Medicine
|
August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C Mutation
Adrian Sacher, Patricia LoRusso, Manish R Patel, et al.
Page
of 17